Cubist Systematic Strategies, LLC Edgewise Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$9.25 - $19.97 $938,680 - $2.03 Million	101,479 Added 5869.23%	103,208 $1.88 Million
Q4 2023 Feb 14, 2024	BUY	$5.51 - $12.1 $9,526 - $20,920	1,729 New	1,729 $18,000
Q3 2022 Nov 14, 2022	BUY	$8.08 - $13.58 $264,838 - $445,111	32,777 Added 286.01%	44,237 $435,000
Q2 2022 Aug 15, 2022	SELL	$5.67 - $9.87 $163,539 - $284,680	-28,843 Reduced 71.57%	11,460 $91,000
Q1 2022 May 16, 2022	BUY	$9.1 - $18.97 $366,757 - $764,547	40,303 New	40,303 $391,000

192

100M

2.17M

410K

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $1.86B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.